C07K 2319/90
Containing a motif for post-translational modification
Official title: containing a motif for post-translational modification
C07K2319/90 (Containing a motif for post-translational modification) appears on 340 US grants and 541 published applications in this corpus.
Search patents in C07K- Granted patents
- 340
- Published applications
- 541
- Assignees
- 343
- Inventors
- 1,170
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 18 | 0 |
| 1999 | 8 | 0 |
| 2000 | 10 | 0 |
| 2001 | 8 | 0 |
| 2002 | 3 | 5 |
| 2003 | 3 | 11 |
| 2004 | 3 | 6 |
| 2005 | 6 | 5 |
| 2006 | 2 | 10 |
| 2007 | 4 | 7 |
| 2008 | 2 | 2 |
| 2009 | 3 | 4 |
| 2010 | 5 | 10 |
| 2011 | 5 | 10 |
| 2012 | 4 | 10 |
| 2013 | 3 | 14 |
| 2014 | 8 | 16 |
| 2015 | 10 | 30 |
| 2016 | 9 | 30 |
| 2017 | 19 | 26 |
| 2018 | 20 | 21 |
| 2019 | 18 | 31 |
| 2020 | 26 | 40 |
| 2021 | 16 | 41 |
| 2022 | 17 | 50 |
| 2023 | 22 | 37 |
| 2024 | 17 | 56 |
| 2025 | 29 | 40 |
| 2026 | 11 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- AAV delivery of nucleobase editors30 Jun 2026US 12,668,815 B2President and Fellows of Harvard College
- Multi-targeted, tunable, sustained delivery of payloads to charged avascular tissues16 Jun 2026US 12,653,899 B2Massachusetts Institute of Technology
- Covalent adaptor synNotch and chimeric antigen receptors (CARs) for programmable antigen-targeting16 Jun 2026US 12,655,213 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Fully humanized bispecific chimeric antigen receptor targeting CD19 and CD22 and use thereof9 Jun 2026US 12,648,995 B2Nanjing IASO Biotechnology Co., Ltd.
- Methods and compositions for prime editing nucleotide sequences12 May 2026US 12,624,353 B2President and Fellows of Harvard College
- Influenza ehead immunogens1 Oct 2026US 2026/0295029 A1The Scripps Research Institute
- Il-22 fc fusion proteins and methods of use1 Oct 2026US 2026/0297150 A1Genentech, Inc.
- Nano-perforator having improved anti-viral activity17 Sep 2026US 2026/0275359 A1Mvrix Co., Ltd.
- Glycosylated neuropeptide derivative including neuropeptide sequence and sugar chain, pharmaceutical composition, intranasal/nasal drop formulation, and use of glycosylated neuropeptide derivative10 Sep 2026US 2026/0265331 A1Tokyo University of Science Foundation
- Chimeric nanobody-decorated liposomes by self-assembly27 Aug 2026US 2026/0250417 A1The Research Foundation for The State University of New York
Most cited
By later US patents
- Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor164US 5,374,548 AGenentech, Inc. · 1994
- Novel receptors for efficient determination of ligands and their antagonists or agonists158US 4,859,609 AGenentech, Inc. · 1989
- Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein146US 5,858,368 AProtein Sciences Corporation · 1999
- Method for producing influenza hemagglutinin multivalent vaccines using baculovirus139US 5,762,939 AMg-Pmc, LLC · 1998
- Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein139US 5,834,247 ANew England Biolabs, Inc. · 1998